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Abstract
T cell receptor (TCR) recognition of peptide-MHC class I (pMHC) complexes is a crucial event in the adaptive immune response
to pathogens. Peptide epitopes often display a strong dominance hierarchy, resulting in focusing of the response on a limited
number of the most dominant epitopes. Such T cell responses may be additionally restricted by particular MHC alleles in
preference to others. We have studied this poorly understood phenomenon using Theileria parva, a protozoan parasite that
causes an often fatal lymphoproliferative disease in cattle. Despite its antigenic complexity, CD8
+ T cell responses induced by
infection with the parasite show profound immunodominance, as exemplified by the Tp1214–224 epitope presented by the
common and functionally important MHC class I allele N*01301. We present a high-resolution crystal structure of this pMHC
complex,demonstratingthatthepeptideispresentedinadistinctiveraisedconformation.Functional studiesusingCD8
+Tcell
clones show that this impacts significantly on TCR recognition. The unconventional structure is generated by a hydrophobic
ridge within the MHC peptide binding groove, found in a set of cattle MHC alleles. Extremely rare in all other species, this
feature is seen in a small group of mouse MHC class I molecules. The data generated in this analysis contribute to our
understanding of the structural basis for T cell-dependent immune responses, providing insight into what determines a highly
immunogenic p-MHC complex, and hence can be of value in prediction of antigenic epitopes and vaccine design.
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Introduction
T cells constitute a key component of the adaptive immune
system, allowing recognition of virtually any pathogen that may
infect the host. Immunity against many intracellular pathogens is
governed by CD8
+ T cells and major histocompatibility complex
(MHC) class I molecules, which bind antigenic peptides within a
groove formed by their alpha 1 and alpha 2 extracellular domains
[1]. Recognition by the clonotypic T cell receptor (TCR) of the
peptide-MHC (pMHC) complex is a critical step in this process,
leading to a variety of responses aimed at elimination of the
pathogen [2]. These processes have been largely characterised in
humans and mice, and while the same immune system
components are found in cattle, an economically important
livestock species, less is known of the detailed cellular and
molecular interactions in this species.
MHC class I genes are highly polymorphic and it is this feature
that determines individual peptide binding characteristics of class I
molecules [3]. Cattle have at least 6 classical MHC class I genes
[4] (contrasting with 3 in human), and variable haplotype
structures, with usually one, 2 or 3 of the genes present and
expressed, in a variety of combinations [5]. We have previously
identified the majority of MHC class I alleles (www.ebi.ac.uk/ipd/
mhc/bola) present in the Holstein or Friesian breed (Bos taurus),
which represents by far the most abundant breed of dairy cattle
throughout Europe and North America and is increasingly being
used to improve milk production in developing countries. MHC
class I allelic diversity in the Holstein/Friesian cattle population is
relatively low in comparison to similarly large human populations,
for example Caucasian; this probably reflects a combination of
founder effect and/or recent strong selection for production traits
(Ellis, manuscript submitted).
ThestructuralbasisforpeptidebindingtoMHCclassImolecules
has been extensively investigated in humans and mice [6,7], less so
for other species [8,9]. The N and C termini of bound peptides
interact with invariant class I residues at either end of the peptide-
PLoS Pathogens | www.plospathogens.org 1 October 2010 | Volume 6 | Issue 10 | e1001149binding groove. Peptides are most often between 8 and 10 residues
in length, and although longer exceptions that adopt a bulged
conformation have been reported in human [10], rat [9] and mouse
[11] these have generally been considered very unusual. The
peptidespecificityexhibited byMHCmolecules isdependent onthe
entire sequence of binding peptides, but is dominated by several key
interactions made by so-called anchor residues. These define a
peptide binding ‘motif’ for a particular MHC allele which usually
consists oftwo ormoreanchorresidues,such that inall peptidesthat
will bind the allele these two residues will be relatively invariant or
have conserved properties. Structural studies have revealed that the
side chains of the peptide anchors interact with polymorphic
residues in a series of pockets in the groove; these define the binding
specificity of the allele [12]. Many peptide binding motifs have been
described in human and mouse, while in cattle peptide binding
properties have been investigated for only a small number of MHC
class I alleles [13,14], and data are insufficiently detailed to allow
meaningful comparison between species.
A characteristic feature of CD8
+ T cell responses to many
pathogens is that the peptide epitopes display a strong dominance
hierarchy, resulting in focusing of the response on a limited number
of the most dominant epitopes [15]. Such T cell responses may be
additionally restricted by particular MHC alleles in preference to
others. This phenomenon impacts substantially on our ability to
design and implement improved vaccines against a range of
pathogens, yet is still poorly understood. We wished to investigate
the basis for this phenomenon using the example of Theileria parva,a
complex protozoan parasite for which the cattle CD8
+ T cell
response has been extensively studied and characterized.
Several CD8
+ T cell epitopes in T. parva have been identified
recently [16,17,18]. Graham et al [18] investigated recognition of
synthetic peptides by antigen-specific CD8
+ T cells and showed
that out of 9 epitopes derived from 6 different T. parva antigens 3
were 11 amino acids long. One of these (Tp1214–224) was shown to
be presented by the cattle MHC class I allele N*01301. This allele
is expressed alone on the haplotype designated A18, which is
common in the British Friesian breed. Although this is not the only
single gene class I MHC haplotype in cattle, it remains an unusual
phenomenon in mammals (where 2 or 3 class I genes are generally
expressed), but is commonly seen in non-mammalian vertebrates
[19]. MacHugh et al [20] showed that in T. parva-immune A18-
homozygous animals, over 75% of responding T cells are specific
for the Tp1214–224 11mer. Animals heterozygous for A18 also
consistently respond to this epitope presented by N*01301 [18,20].
Dominant CD8
+ T cell responses restricted by this allele have in
addition been reported for respiratory syncytial virus [21] and foot
and mouth disease virus [22].
Determination of the structural and biophysical characteristics of
pMHC interactions can lead to a better understanding of T cell
recognition and T cell-dependent immune responses. Unique
features of the MHC in cattle [23], and the pressing requirement
for improved vaccines and other disease control measures in livestock
[ 2 4 ] ,m e a nt h a ti n c r e a s i n go u rk n o w l e d g ei nt h i sa r e aw i l ln o to n l y
shed light on evolution of the mammalian immune system but will
also be of practical benefit. Herew ed e s c r i b et h ep e p t i d eb i n d i n g
properties of the common and functionally important cattle MHC
class I allele, N*01301. We also describe, at atomic resolution, the
crystal structure of N*01301 bound to an immunodominant 11mer
Theileria parva-derived peptide, Tp1214–224. This analysis provides
important clues regarding the features that determine immunodo-
minance of this pMHC structure. As far as we are aware, this is the
first description of an MHC structurefrom a commercially important
mammalian livestock species.
Results
Peptide Binding Characteristics of N*01301
A 9mer self-peptide (TIMPKDIQL) shown to have a high
binding affinity to N*01301 was used throughout as a positive
control in flow-based MHC stabilization assays (see Materials and
Methods for details). In order to systematically explore the relative
contribution to binding affinity made by amino acids at each
position, a sequential alanine-scan of the self-peptide was made
(Fig. 1A). Dose/FI curves were created for each peptide (using
peptides at concentrations between 0.1 nM and 1 mM) and
presented as semi-logarithmic plots as in previous studies ([25],
supporting information (SI) Fig. S1). The high binders have low
half-maximal binding level (BL50) values (high pBL50) and the low
binders have high BL50 values (low pBL50). Peptides that did not
reach 50% of the binding level of the reference peptide were
considered non-binders. The pBL50 ranges are: for low binding
,4 (BL50 .10
25), for intermediate binding between 4 and 5, and
for high binding .5 (BL50 ,10
25). A parallel study was performed
using the 11mer T. parva-derived epitope Tp1214–224 VGYPKV-
KEEML ([17], Fig. 1B).
N*01301 binding affinities for most of the Ala-substituted
versions of the 9mer self-peptide demonstrated only minor
differences, with three exceptions. The conversion to Ala of Leu
at the C-terminal position, Ile at position 2 (P2) or Lys at position 5
resulted in a substantial loss of binding, while a peptide with Ala
substitutions at positions 2 and 5 showed an even greater loss of
binding. Peptides substituted at positions 2 and 9 or 5 and 9 were
non-binders (or binding was ,50% of the reference peptide).
These results suggest that Ile, Lys and Leu are anchors at positions
2, 5 and 9 respectively. These findings are in partial agreement
with previous work on the N*01301 allele which identified Ile as
an auxiliary anchor at position 2, and Lys as a preferred residue at
position 5 [14].
N*01301 binding affinities for most of the Ala-substituted
versions of the 11mer Tp1214–224 peptide also demonstrated only a
few differences (Fig. 1B). Similar to the self peptide, the Ala-
substitution or removal of the C-terminal Leu resulted in the
Author Summary
CD8
+ T cells are essential for host defense to many
intracellular pathogens. The CD8
+ T cell receptor (TCR)
detects small peptide fragments presented at the surface
of infected cells. These peptide epitopes are bound by
major histocompatibility complex (MHC) molecules. Such T
cell responses are often inexplicably focused on a very
small number of epitopes, even in response to large and
complex pathogens. These epitopes are usually presented
by specific MHC molecules. This phenomenon is known as
immunodominance. An increased understanding of the
factors involved in immunodominance would increase our
ability to design more effective vaccines against a range of
infectious pathogens. Our study focused on an econom-
ically important protozoan parasite of cattle, Theileria
parva. We generated crystals of MHC molecules bound to
an immunodominant T. parva epitope. Analysis of the
crystal structure demonstrated that the peptide was held
in a highly unusual conformation, which was shown to
impact significantly on TCR recognition, based on studies
of specific CD8
+ T cell clones. These data will aid our
understanding of the structural basis for T cell immunity
and will ultimately contribute to development of disease
control strategies.
Presentation of a Theileria parva CD8
+ Epitope
PLoS Pathogens | www.plospathogens.org 2 October 2010 | Volume 6 | Issue 10 | e1001149largest loss of peptide binding for a single substitution/deletion.
Ala-substitution of Lys at position 5 also resulted in a substantial
loss in binding. In contrast to the 9mer peptide, substitution at
position 2 of the 11mer, which in this case was Gly, had no effect.
A peptide with positions 5, 7 and 11 Ala-substituted was a non-
binder. Peptides were also synthesized that probed how varying
the length of Tp1214–224 would affect its ability to bind N*01301.
Removing one residue from the N terminus of this peptide resulted
in no appreciable difference in binding, which suggests this shorter
peptide binds in a similar fashion to Tp1214–224. However this
10mer was not recognized by CD8
+ T cells, suggesting that
removal of residue 1 alters the conformation of the bound peptide
[18]. This is therefore only partially consistent with observations
made for HLA-A*0201 crystal structures [26], that revealed
octamer and nonamer versions of a peptide binding with the same
conformation, due to replacement of the missing N-terminal
residue with water molecules.
Additions to the N terminus, of either a Cys which is the
naturally occurring amino acid within the T. parva protein, or a
Cys and two Ala also had little effect. It is possible that an altered
N-terminal residue would occupy the same pocket as the Val
found in Tp1214–224, while additional residues are likely to extend
out of the binding groove, as reported for a mouse H-2K
b-bound
peptide [27]. These findings suggest that while the C-terminal Leu
is the most crucial residue ensuring peptide binding to the
N*01301 allele, amino acid changes at other positions can also
substantially reduce binding, even if the Leu is present. The
relative importance of these other positions is likely to differ
Figure 1. Peptide binding to N*01301. pBL50 values obtained with N*01301 using an RMA-S stabilization assay, (see Materials and Methods for
explanation), (A) for the reference peptide (TIMPKDIQL) and Ala-substituted peptides and (B) forTp1214–224 (VGYPKVKEEML) and Ala- substituted
peptides.
doi:10.1371/journal.ppat.1001149.g001
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peptide binding groove.
Overview of Cattle MHC Class I N*01301 Structure
The N*01301- Tp1214–224 complex yielded well-ordered
crystals, high resolution x-ray diffraction data were collected and
the structure determined by molecular replacement (see Materials
and Methods and Table S1 for details). The overall structure of
N*01301 resembles that of other mammalian MHC class I
molecules ([3], Fig 2A). Comparison with pMHC structures from
other species indicates that the orientation of the N*01301 a3
domain relative to the rest of the MHC class I molecule lies within
the range reported for mouse pMHCs [11,27], but is distinct
compared to the average position of human a3 domains, with a 5–
7u clockwise rotation relative to the molecular long axis. However,
the N*01301 a3 domain does not show the large (14–29u)
differences in orientation found between the human molecules and
chicken BF2*2101 [8]. This particular orientation of the a3
domain may have some effect on biophysical characteristics of the
species-specific interactions of the cattle a3 domain with other
molecules in the immunological synapse.
The N (position 1, P1) and C (PV) termini of the Tp1214–224
peptide conform to the canonical pMHC class I binding mode,
anchored in the A and F pockets respectively of the N*01301
binding groove (Fig. 2B, Fig. S2). The P1-Ca/PV-Ca distance of
22A ˚ is typical of pMHC complexes [28] and, as reported for other
11mer peptide complexes [10], requires a substantial portion of
the peptide to bulge out of the binding groove (Fig. 3A). In the
N*01301- Tp1214–224 complex the bulged conformation is tethered
to the binding groove at P5 and P9 with residues P6-P8
prominently exposed at the pMHC surface (Fig. 3A). The peptide
conformation appears to be relatively rigid (the electron density is
well-defined for the full-length of the peptide, Fig. 3A) and is not
the result of stabilizing interactions with neighboring molecules in
the crystal (the peptide does not contribute to any major crystal-
packing contacts). This is in contrast to the flexibility in peptide
conformation observed for some of the previously determined
highly bulged pMHC structures [29,30,31].
The overall architecture of the N*01301 binding groove and the
peptide main chain conformation is typical of pMHC complexes
for positions 1–3 (P1-P3). At P2 the conformation is stabilized by
van der Waals (VDW) contacts with Tyr7 in pocket A and
hydrogen bonding with Glu63 in pocket B (Fig. S2). In the absence
of a P2 side chain (P2 is a Gly in Tp1214–224), pocket B is occupied
by three bound water molecules. Displacement of one or more of
these water molecules could provide sufficient space for pocket B
to accommodate an alanine side chain, consistent with our Ala-
substituted Tp1214–224 binding data (Fig. 1B). The P3 main chain
is tethered by an interaction with Tyr99 (Fig. S2), while the P3 side
chain (tyrosine) is anchored in pocket D by hydrophobic stacking
with Arg155 (Fig. 3C). Arg155 also interacts with the peptide
through hydrogen bonding to the main chain at P4 and the side
chain of the Glu P9 residue.
Electrostatic potential calculations show that the central region
of the N*01301 binding groove displays strong electronegative
potential (Fig. S4), augmented by Glu114 which is involved in a H-
bond network with Glu97 as well as with water molecules present
in pockets C and D. Glu97 points up from the floor of the groove
to hydrogen bond to the Lys side chain of P5 (Fig. 3B). This
interaction results in P5 extending deep into the binding groove,
the side chain conformation further stabilized by hydrophobic
stacking with Trp73. Thus, consistent with our peptide binding
data, Lys at P5 acts as a major anchor residue. The main chain
conformation of the P6-P8 bulge is stabilized by partial hydrogen
bonds of the P6 and P9 carbonyl oxygens to the Ne of Trp73 as
well as intra-peptide bonds between the same carbonyl atoms and
the main chain nitrogen atoms at P7 and P8. The bulky Trp73
residue thus appears to play a defining role in the location and
stabilization of the P6-P9 bulge conformation (Fig. 3B and C). The
peptide main chain dips back into the binding groove at P9, the
Figure 2. Overview of the structure of N*01301. (A) The heavy
chain is shown in cyan, b2m in purple, and the peptide in yellow (B) Top
view of the binding platform showing the bound peptide Tp1214–224 in
stick format with residues labeled.
doi:10.1371/journal.ppat.1001149.g002
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bond to Arg155. Finally, the Leu side chain at PV is anchored in
pocket F by hydrophobic interactions with residues Tyr116,
Met147, Ala77, Leu81 and Tyr123 (Fig. S2).
Overall the binding of Tp1214–224 to N*01301 results in an
interface of 1040 A ˚ 2, one of the most extensive interface areas for
canonical pMHC complex structures reported to date (Table S2).
Most of the pMHC interfaces for human alleles average no more
than 900 A ˚ 2 and structures for other species reveal that only mouse
MHC class I molecules engage consistently through interfaces
nearing the N*01301 value. While forming this extensive interface,
the Tp1214–224 peptide also presents a substantial number of
surface-exposed residues for T cell receptor (TCR) recognition,
namelyP1(Val),P4(Pro),P6(Val),P7(Lys),P8(Glu)andP10(Met),
(Fig. 3A, Fig. S5).
Comparison to Other MHC Class I Structures
Least squares superpositions of the binding groove of cattle
N*01301 with all available pMHC crystal structures allowed a
comparison of key features. Figure 4 (A, B) shows a comparative
overlay of the N*01301 bound peptide Tp1214–224 with a number
of representative longer (.10mer) peptides from other pMHC
structures. Structures reported to have flexible or multiple peptide
conformations were not included [29,30,31]. All of the peptides
have standard N- and C-terminal positions within the binding
groove. The human alleles HLA-B*35 and B*57 bind longer
peptides up to 14 residues in length [29]. Examples are shown in
Figs 4A and B together with an 11mer peptide bound to chicken
BF2*2101 [8]. The canonical N- and C- terminal anchor positions
can be spanned by 8mer and 9mer peptides in relatively extended
conformations; longer peptides are accommodated by adopting
either zig-zag conformations within the groove or bulging out of
the groove (Fig. 4B). Tp1214–224 is distinctive in having the bulge,
P6–P8, located nearer the C-terminal end of the binding groove
than the other examples of bulged-type conformations.
There are many HLA-B*35 structures (*3501 and *3508)
binding both short (9mer) and longer peptides (11–14mers); the
latter for the most part bulge centrally. Only two examples of long
peptides out of fifteen available structures display C-terminal
bulging; both are bound to HLA-B*3508 (Fig. 4A and 4B: 11mer
in yellow [32]; 12mer in red [30]). Of these the 12mer bulges out
closer to the C terminal end of the B*3508 binding groove (P7–
P10) than any other human class I-bound peptide, but this bulge is
still somewhat less C-terminal than its counterpart in Tp1214–224
(PV-2 and PV-1 are surface exposed, respectively). In both the
HLA-B*3508-11mer and -12mer structures the C-terminal bulge
position results from P5 (Glu) acting as a secondary anchor,
forming salt bridges to Arg97 and Arg156. The use of P5 as an
anchor in Tp1214–224 also involves interaction with N*01301
residue 97 but in this case P5 is the positively charged residue Lys
interacting with the negatively charged Glu97; there is no
interaction with residue 156 (Phe), but there is instead an
additional interaction with Trp73. Figure 4C shows the effect of
TCR binding for a second HLA-B*3508-11mer complex [31].
The peptide in this case has adopted a ‘flattened’ conformation
that bulges more towards the C terminus of the peptide binding
groove compared to its non-TCR bound equivalent [28].
The above analysis highlights the contribution of Trp73 to two
distinctive characteristics of the N*01301 groove: the preference
for Lys as a P5 anchor residue and the main chain conformation of
Figure 3. Conformation of the bound peptide. Conformation of
the bound peptide Tp1214–224 shown from the a2 helix side of the
binding groove, unless stated otherwise. (A) The corresponding 2Fo-Fc
electron density is shown in mesh format. The peptide is in stick format
with each amino acid labeled (B) View onto the binding groove (as in
Fig. 2B) additionally showing Trp3 and Glu9 of Tp1214–224, and Arg155
of N*01301. Hydrogen bonds are denoted by dotted grey lines (C) The
peptide backbone is shown as a cartoon ribbon in gold. The Lys at
position 5 of Tp1214–224 and the Asn, Glu and Trp at positions 70, 97 and
73 respectively of N*01301 are shown in stick format.
doi:10.1371/journal.ppat.1001149.g003
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P9 (PV-2) residue on the a2 helix side of the binding groove at a
position distinct from those of PV-2 residues in human pMHC
structures (Fig. 4B and Fig. S3). Tryptophan at position 73 is
extremely uncommon. It does not occur in MHC class I sequences
of any of the species included in the immunopolymorphism
database (www.ebi.ac.uk/ipd/mhc) or in human, where this
position is occupied almost exclusively by Ala or Thr (www.ebi.
ac.uk/imgt/hla/). In cattle it occurs only in N*01301 and in 5 very
closely related alleles, all encoded at the same locus (Table 1). In
contrast Trp73 is relatively common in mouse MHC class I
molecules, occurring in ,25% of alleles including L
d,L
q,D
q and
D
b. In mouse it is always accompanied by Tyr at position 156,
which together with Trp at 147 produces a hydrophobic ‘ridge’
that forces the bound peptide out of the groove [11]. A
comparable ridge, formed by Tyr152, Trp70 and Tyr9 is seen
in the rat RT1-A
a molecule [9]. Cattle N*01301 has Trp at 73 and
Met at 147, which together would be predicted to form a similar
feature, conserved in the alleles included in Table 1.
Figs 4D and E show peptides bound to several mouse MHC
class I molecules. In H-2D
b, which exhibits the hydrophobic ridge,
P5 is a central anchor point as in the cattle structure. The side
chain of the P5 residue, in this case an Asn, reaches deep into the
binding groove and occupies the same position as the Tp1214–224
Lys, interacting with residues at the bottom of the groove. As a
consequence of the smaller side chain, the P5 Ca backbone is
Figure 4. Comparison of structures. Peptide Tp1214–224 bound to
N*01301 (cyan), compared to peptides in other mammalian pMHC
structures. View shows the Ca-traces of the bound peptide from the a2
helix side of the binding groove, unless stated otherwise. (A) Long
peptide comparison: 11mer peptide (green, PDB accession code 3BEV)
bound to chicken B21; 11mer (gold, PBD code 2FZ3), 12mer (red, PBD
code 3BW9) and 13mer (orange, PBD code 1ZHL) peptides bound to
HLA-B*3508; 11mer peptides (purple, PBD code 2BVQ; grey, PBD code
2BVO) bound to HLA-B*5703. (B) Long peptide comparison: view onto
the binding groove of Fig. 4A. (C) Long peptide comparison: 11mer
peptide bound to HLA-B*3508 (blue, PDB code 1ZSD), and its
conformation change upon TCR binding (pink, PDB code 2NX5).
Peptide Ca backbone positions are denoted by P1-PV for Tp1214–224. (D)
Mouse comparison: 9mer peptide (red, PBD code 1CE6) and 11mer
peptide (blue, PBD code 1JPF) bound to H-2D
b; 10mer peptide (brown,
PBD code 1BII) bound to H-2D
d; 8mer peptide (green, PBD code 1FO0)
bound to H-2K
b; 9mer peptide (pink, PBD code 1VGK) bound to H-2K
d;
9mer peptide (yellow, PBD code 1ZT1) bound to H-2K
k. (E) Mouse
comparison: view onto the binding groove of Fig. 4D.
doi:10.1371/journal.ppat.1001149.g004
Table 1. Amino acid residues at positions 73 and 147 in 7
cattle MHC class I alleles.
Allele 73 147
N*01301 W M
N*01302 W M
N*01401 W W
N*01402 K
1 W
N*01501 W M
N*01502 W M
N*04101 W M
1BoLA N*01402, which has Lys in place of Trp at position 73, has only been
recorded once (www.ebi.ac.uk/ipd/mhc/bola); Lys at position 73 has not been
observed in any other cattle class I allele.
doi:10.1371/journal.ppat.1001149.t001
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with Trp73 in the same way, with its P6 and P9 carbonyl oxygens
forming similar partial hydrogen bonds to the Ne of Trp73. Thus
the characteristics of the cattle N*01301 binding groove are most
similar to those of the mouse MHC class I molecules, in particular
H-2D
b.
Recognition of the N*01301-Tp1214–224 Structure by CD8
+
T Cell Clones
Since the characteristics of the N*01301- Tp1214–224 structure
(i.e.highlystable,largeareaexposed toTCR,unusual positioningof
the peptide bulge) suggest it may have a major impact on TCR
recognition, we performed functional studies to determine the fine
specificity of T cell recognition. Twenty-two Tp1214–224-specific
CD8
+ T cell clones, derived from 2 T. parva-immune animals (641
and 633), were examined for their ability to recognize a series of
Ala-substituted versions of Tp1214–224 (as detailed in Fig 1), using a
cytotoxicity assay. All clones gave near maximal levels of killing of
cells pulsed with the native peptide (ranging from 21% to 100% for
different clones) down to a concentration of 10 pg/ml (example
shown in Fig S6). The results obtained with the Ala-substituted
peptides tested at 1 ng/ml (i.e. well above the minimal concentra-
tion required to obtain maximal killing), are summarized in Fig 5.
The most striking finding was the abolition (or near abolition) of
recognition by all T cell clones of 2 or more of the peptides
substitutedatpositions6–9.Basedonmajoreffectsonrecognitionof
peptides substituted at positions 6, 7 and 8, the 22 clones fell into 4
groups each with broadly similar specificity. Nine clones were
profoundly influenced by residues 6 and 8, seven clones by residues
7 and 8, four clones by residue 7 and two clones by residue 8.
Substitution of position 9 profoundly reduced recognition by all 22
clones. Substitutions at positions 3 and 4 also had substantial effects
on recognition by some clones.
The evidence that residues 6–9 are involved in epitope
recognition by all T cell clones indicates that the CD8
+ T cell
response is focused on the bulged region of the bound peptide.
Although Glu at P9 lies deep within the groove, it is predicted to
stabilize the structure, hence substitution of this residue is likely to
radically alter the surface topography of the peptide. Typing of 19
of the T cell clones for expressed TCR Vb gene subfamilies [33]
demonstrated that 2 different subfamilies (Vb1 and Vb3) were
represented in the clones from both animals (Fig 5). This is
consistent with previous data from Vb analysis of both cultured T
cell lines and ex vivo CD8
+ T cells from T. parva-immune cattle,
which showed that the response to dominant epitopes, although
polyclonal, contains a small number of highly abundant clonotypes
[20,33]. However, the results obtained here with the Ala-
substituted peptides showed that the Vb1
+ and Vb3
+ clones each
contained different fine specificities, indicating that these clones
included different TCR rearrangements, either at the level of the
CDR3 sequence or the paired a chain. Hence focusing of the
responding T cells on the bulged region of the bound peptide
occurred irrespective of the TCR chain rearrangements.
The results shown in Fig 5, using a saturating concentration of
peptides (1 ng/ml), reveal the residues that have major effects on
Figure 5. Effects of single alanine substitutions in the Tp1214–224 epitope on recognition by specific CD8
+ T cell clones. T cell
recognition was examined using a 4-hour
111Indium release cytotoxicity assay employing target cells incubated with 1 ug/ml of peptide. The
maximum level of cytotoxicity obtained with the native Tp1214–224 peptide is shown for each clone. Killing of unpulsed target cells was ,2% for all
clones. The degree of reduction in killing obtained with each of the single Ala substituted peptides (A1–A11) compared to that obtained with the
native Tp1214–224 peptide is represented as follows: 0–20% reduction (white); 21–40% reduction (pale grey); 41–60% reduction (medium grey); 61–
80% reduction (dark grey); 81–100% reduction (black). The expressed TCR Vb genes were identified using Vb subfamily-specific PCR assays. NT=not
tested.
doi:10.1371/journal.ppat.1001149.g005
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predicted anchor positions (P5 and 11) had only minor and
variable effects on T cell recognition of targets at this peptide
concentration. However, substantially reduced recognition relative
to the native peptide was observed at lower concentrations,
particularly when P11 was substituted (Fig S6). These results
indicate that peptides containing single substitutions in the anchor
residues retain some MHC-binding activity at high peptide
concentrations. Analysis of peptides with multiple Ala-substitutions
(P5 and 11, or P2, 5 and 11) demonstrated that these substitutions
abolished T cell recognition, consistent with the binding data from
MHC stabilization assays.
Discussion
The cattle pMHC class I structure described here demonstrates
that peptides presented by N*01301 are held in an unusual
conformation likely to impact significantly on TCR recognition.
Binding studies defined the putative anchor positions involved in
peptide binding to N*01301 to be P2, P5 and the C-terminal
residue. Their relative importance, however, differs depending on
length and composition of the peptide. Overall, the binding data
suggest that a hydrophobic residue at the C-terminus and an
anchor residue Lys at position 5 define the binding motif of
N*01301. Functional studies using CD8
+ T cell clones comple-
ment and add to these data, and support the suggestion that the
unusual peptide conformation impacts significantly on T cell
recognition.
A number of residues within the N*01301 binding groove are
involved in the unusual positioning of the 11mer peptide. Position
97 Glu exerts a strong influence on the P5 Lys, pulling it deep into
the groove and helping to restrict the bulge in the peptide to its C-
terminal end. An anchor at P5, or anywhere in the central region
of the peptide, is unusual in human MHC and has only been
described with HLA-B *08, B*14, B*15, B*35 and B*51. Of these
only B*35 is known to bind unusually long peptides (.10 residues),
but even when central anchors are involved the peptide bulge does
not take on the conformation shown in the N*01301 structure
([31] Fig. 4A, 4B).
The Trp73 residue is most influential in positioning of the
peptide bulge, as described in detail in the Results section. While
extremely rare in other species, this feature is found in a number of
mouse MHC class I alleles, such as H-2D
b, forming part of a
hydrophobic ‘ridge’ that cuts across the peptide binding groove
[11]. The Trp73 residue, which contributes to this structural
feature, is found only in a small group of closely related cattle class
I alleles (Table 1) encoded by class I gene 6 [4,5]. In the mouse the
Trp73 residue is seen in alleles encoded at more than one locus,
but Ciatto and colleagues [11] argue for the existence of a ‘related’
family of alleles having a tight evolutionary relationship, possibly
with a common progenitor. These authors go on to suggest that
the resultant structure of these alleles focuses the conformational
variability of the bound peptides in a position that allows optimal
TCR interaction, and for this reason propose that evolution has
led to conservation of this feature.
Studies of human CTL responses have shown that peptides of
between 8 and 10 residues in length constitute the majority of
epitopes presented by MHC class I molecules. Recent studies have
identified a very small number of longer epitopes that are
presented by HLA-B*35 [10,28,29]. Typically, non-canonical
peptides of .10 amino acids in length bulge from the peptide-
binding cleft and there is evidence that this feature can result in
biased selection of the TCR repertoire [30,31]. Results suggest
that a rigid bulge in the peptide can lead to selection of a specific
T-cell repertoire showing limited diversity, in some instances
including public TCR specificities with conserved Vb and CDR3
sequences. In a number of reported cases the structure is flexible
allowing the epitope to be flattened by the TCR interaction
(Fig. 4C), providing a more standard landscape; this leads to a
diverse TCR profile [31]. The peptide conformation in our
structure appears to be relatively rigid and results in an extensive
interface area with the binding groove. A likely consequence of
such an extensive association is that the strength of this interaction
could be substantial and there would be little conformational
adaptability of the peptide upon TCR docking, which might imply
a smaller energetic penalty upon complex formation with TCRs.
We predict that shorter (9 or 10mer) peptides would interact in the
same way with the peptide binding groove, with similar impact on
T cell recognition.
Data generated using CD8
+ T cell clones specific for Tp1214–224
complement conclusions derived from the structural analysis, and
support the suggestion that the unusual positioning of the peptide
has a role in the immunodominance of this epitope. Recognition
by all 22 CD8
+ T cell clones studied was disrupted by Ala
substitutions in those residues forming the rigid, bulged part of the
peptide (P6–P9), with additional variable effects observed with
substitutions at other positions, notably P3 and P4. P9 appears to
be a particularly critical residue affecting recognition by all T cell
clones. Typing of the T cell clones for TCR Vb gene expression
revealed that all 19 clones examined expressed gene segments
belonging to the Vb1 and Vb3 subfamilies, although the data
obtained with Ala-substituted peptides demonstrated different fine
specificities among clones expressing the same Vb gene, indicating
different TCR rearrangements. Hence focusing of recognition on
the bulged region of the peptide was apparent irrespective of the
expressed TCR gene rearrangements of the T cells. The key role
played by P9 in influencing T cell recognition is consistent with the
structural findings which show this to be the point at which the
peptide main chain dips back into the binding groove, making
several strong interactions and having a key role in positioning and
stability of the bulged section of peptide. Substitution of P9 would
therefore be predicted to disrupt both the shape and stability of
this region, thus abrogating TCR recognition. The structural data
together with the functional results reinforce the crucial nature of
peptide conformation in determining the fine specificity of the T
cell response.
It is of interest that the N*01301 allele is only found expressed in
isolation on the haplotype designated A18. Extensive analysis of
animals homozygous for this haplotype indicates that no other
classical class I genes are present or expressed [34]. A number of
other cattle MHC haplotypes have been identified that also
express a single class I gene. Unlike chickens, which have a single,
dominantly expressed class I gene [18], such a phenomenon is
unusual in mammals, where two or three classical class I genes are
usually expressed. The A18 haplotype is very common in British
Friesian cattle, which represent a sub-population of the Holstein/
Friesian breed and although these animals are subject to artificial
selection, it does suggest that this MHC haplotype does not place
them at a major immunological disadvantage. Studies of CD8
+ T
cell responses to T. parva have demonstrated a hierarchy of
dominance in the MHC restriction of the response, with some
MHC haplotypes consistently being dominant in preference to
others. The dominant restriction elements on these haplotypes
include N*01301 and other related alleles shown in Table I, which
share the ‘A6’ supertypic class I serological specificity [35] and are
predicted to have the hydrophobic ridge likely to result in an
unusually positioned peptide. A recent study of CD8
+ T cell
responses to foot and mouth disease virus (FMDV) in cattle also
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(both homozygotes and heterozygotes) gave a consistently strong
N*01301-restricted response to the virus [22]. These data support
the hypothesis that this group of alleles demonstrates a common
characteristic leading to pMHC/TCR structures that tend to
generate dominant CD8
+ T cell responses.
Despite the antigenic complexity of T. parva, the genome of
which is predicted to encode .4,000 proteins [36], CD8
+ T cell
responses induced by infection with the parasite show profound
immunodominance, in some cases resulting in the majority of the
response being focused on a single epitope, as observed with
Tp1214–224 [20,35]. Moreover, immunodominance of this epitope
was found to be retained in A18
+ cattle immunized with Tp1 and
four additional T. parva antigens, delivered by a prime boost
protocol in separate vaccine constructs [18]. These findings imply
that Tp1214–224 presented by N*01301 is inherently highly
immunogenic. There is evidence that immunodominance can be
influenced at different levels including the generation of an
appropriate TCR repertoire, the abundance and turnover of the
proteins from which epitopes are derived and the affinity of the
peptides for the MHC [15]. Complex pathogens such as Theileria
parva are likely to generate many abundant peptides capable of
binding to a particular MHC class I allele, for which specific T
cells are present in the repertoire. Hence there must be additional
factors that determine the dominance of a particular epitope. The
results shown in the present study indicate that the very prominent
C-terminal bulge of the Tp1214–224 11mer when presented by
N*01301 and the highly stable nature of the structure, are likely to
be key factors in determining the dominance of this epitope over
other parasite peptides bound by N*01301.
Immunodominance of CD8
+ T cell responses to a range of
pathogens in human and animal is well-documented and has been
shown to result in strain-specificity of responses, allowing escape
from immune recognition. Thus the results reported here are not
only of fundamental biological interest but also of practical
relevance. Defining how diverse peptides bind to different MHC
molecules leads to an improved understanding of the structural
basis for T cell dependent immune responses. This provides insight
into what determines a highly immunogenic peptide-MHC
complex and hence can be of value in prediction of antigenic
epitopes and vaccine design.
Materials and Methods
Identification of a N*01301 Self Peptide
Analysis of peptides bound to the cattle MHC class I allele
N*01301 (formerly named HD6) was described in Gaddum et al
[14], when a partial binding motif was identified. Subsequently a
complete self peptide derived from an eluted peptide pool was
sequenced and identified as TIMPKDIQL which is derived from
Histone H3.
Peptide Binding Using Stabilization Assay
RMA-S is a mouse lymphoma cell line with a deficiency in
MHC class I antigen processing which has been used extensively
to study binding of peptides to MHC class I [37]. RMA-S cells
were stably transfected with N*01301 in pcDNA6 and assays
performed as described using a mAb (IL-A88, [38]) specific for
cattle class I and that recognizes all alleles to detect stable surface
expression of N*01301. Peptides were synthesized with fluorethyl-
methoxy-carbonyl (fMOC) chemistry (Peptide Protein Research
Ltd, Southampton, UK) and purified in-house to .98%. Peptides
were used at concentrations between 0.1 nM and 1 mM in steps of
10 fold dilution. Results are expressed as fluorescence index (FI)
values. These were calculated as the test mean fluorescence
intensity (MFI) minus the no-peptide isotype control MFI divided
by the no-peptide N*01301-stained control MFI minus the no-
peptide isotype control MFI. The half-maximal binding level
(BL50), which is the peptide concentration yielding the half-
maximal FI of the reference peptide in each assay, was calculated
and presented as pBL50 (–logBL50). The N*01301 self peptide
TIMPKLIDQ, which binds with high affinity, was used as a
reference peptide.
Protein Expression, Purification and Complex Assembly
The N*01301 expression construct (amino acids 25–279 of
N*01301 plus N-terminal His-tag and C-terminal biotinylation
sequence) was generated by ligation-independent cloning (Gate-
way Technology, Invitrogen) into pOPINI [39], over-expressed in
Escherichia coli RosettaBlue (DE3) pLacI (Novagen) as inclusion
bodies (IB), dissolved in appropriate urea-containing buffers and
purified using Ni affinity chromatography. This construct was
generated following extensive high-throughput screening using the
facilities and expertise of the Oxford Protein Production Facility
(www.oppf.ox.ac.uk). Cattle b2m cDNA [40] was cloned into
pet24a(+) (Novagen), expressed as IB in BL21-CodonPlus (DE3)-
RP competent cells (Strategene), and subsequently isolated and
dissolved in urea-containing buffers. The denatured proteins were
re-natured in the presence of the Tp1214–224 peptide for 3 days,
concentrated and purified by FPLC (fast protein liquid chroma-
tography) with a HiLoad 26/60 Superdex 75 column (Pharmacia).
Crystallization and Data Collection
Renatured Tp1214–224- N*01301 was concentrated to 6.6 mg/
ml in 150 mM NaCl, 20 mM Tris (pH8.5) and crystallized in 20%
(wt/vol) PEG 8000 and 50 mM potassium di-hydrogen phosphate
using the sitting drop vapor diffusion method. Crystals were briefly
transferred to a cryoprotectant solution prior to flash-freezing at
105 K. The crystals diffracted to 1.8 A ˚ resolution; diffraction data
were collected at the European Synchrotron Radiation Facility
(Grenoble, France) on beamline ID14.2 by using a Quantum 210
charge-coupled device detector (Area Detector Systems, Poway,
CA). The X-ray data were processed and scaled with the HKL
suite ([41]; Table S1).
Structure Determination and Analysis
The structure was determined by molecular replacement using
HLA-B*5703 (2BVO.pdb) as a search model in AMoRe [42].
Initial rigid body refinement was followed by a series of restrained
TLS refinements performed using REFMAC [43] to Rwork of
19.9% and Rfree 23.9%. Manual rebuilding was carried out in
COOT [44]. Continuous density allowed unambiguous model
building of N*01301. No density was visible for the N-terminal His
tag or the C-terminal biotinylation signal, which are presumably
flexible. Crystallographic statistics for the final models are given in
Table S1. All figures of molecular models and electron density
were generated in PyMol supplied by Delano Scientific LLC
(www.pymol.org) and electrostatic potential was calculated using
APBS [45] through the Pymol interface. The atomic coordinates
and structure factors are deposited in the Protein Data Bank
(www.pdb.org): ID code 2xfx (coordinates) r2xfxsf (structure).
Analysis of Recognition by CD8
+ T Cells
CD8
+ T cell clones specific for Tp1214–224 and restricted by
N*01301 were derived from 2 cattle, 641 and 633 (MHC class I
types A18/A18 and A18/A31), which had been immunized with
the Muguga strain of T. parva by infection and treatment [46]. The
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described previously [47]. They were expanded and maintained in
48 well culture plates by stimulation at 10–14 day intervals with c-
irradiated autologous parasitized cells in RPMI culture medium
containing 10 mM HEPES buffer, supplemented with 10% heat-
inactivated fetal bovine serum, 5610
25 M 2-mercaptoethanol,
2 mM L-glutamine, 50 mg/ml penicillin/streptomycin, and 100
units/ml human interleukin-2 (Chiron Corporation, Emeryville,
CA., USA). The specificity of the CD8
+ T cell clones was analyzed
using a 4 hour Indium oxide (
111In, Amersham Medical)-release
cytotoxicity assay [47]. Target cells consisted of autologous T.
annulata-transformed cell lines pulsed with peptides as described by
MacHugh et al [20]. The T cell receptor Vb genes expressed by
the T cell clones were identified by PCR analysis of cDNA using
bovine Vb subfamily-specific primers as described by Connelley et
al [33].
Supporting Information
Figure S1 Semi-logarithmic dose/FI curves. The self peptide
TIMPKDIQL was used as a reference. High binders have low
BL50 values (high pBL50, pBL50=logBL50) and low binders have
high BL50 values (low pBL50). Peptides that did not reach 50% of
the binding level of the reference peptide were considered non-
binders.
Found at: doi:10.1371/journal.ppat.1001149.s001 (1.94 MB TIF)
Figure S2 Structural peptide comparisons. Structure compari-
son of the 11mer peptide Tp1214–224(cyan) as bound to N*01301,
with peptides bound in various mammalian class I classical MHCs.
View shows the Ca-traces of the bound peptide from the a2 helix
side of the binding groove, unless stated otherwise.(A) Human
allele comparison: HLA-A2 bound 10mer (pink, PBD code 1I4F),
HLA-B8 bound 9mer (brown, PBD code 1M05), HLA-B14 bound
9mer (purple, PBD code 3BVN), HLA-B15 bound 9mer (grey,
PBD code 3C9N), HLA-B27 bound 9mer (orange, PBD code
2BST), HLA-B35 and 10mer (red, PBD code 2AXG), HLA-B44
bound 10mer (blue, PBD code 3DX9), HLA-B51 bound 9mer
(yellow, PBD code 1E27) and HLA-B57 bound 9mer (green, PBD
code 2BVP). (B) Human allele comparison: view onto the binding
groove of panel A. (C) Species comparison: B21 Chicken bound
11mer (green, PBD code 3BEV), Macaque Mamu-A*01 bound
8mer (pink, PBD code 1ZVS), Rat RT1-A bound 9mer (red, PBD
code 1KJM), and Mouse H-2D
d bound 10mer (purple, PBD code
1BII). (D) Species comparison: view onto the binding groove of
panel C.
Found at: doi:10.1371/journal.ppat.1001149.s002 (6.33 MB TIF)
Figure S3 N*01301 binding groove - surface representation.
Surface representation of the N*0301 binding groove with the
Tp1214–224 peptide in gold as either (A) a molecular model or (B) a
molecular surface. The electrostatic potential on the N*01301
solvent accessible surface has been coloured from blue (electro-
positive) to white (neutral) to red (electronegative) with increasing
color intensity depicting stronger electrostatic potential.
Found at: doi:10.1371/journal.ppat.1001149.s003 (6.12 MB TIF)
Figure S4 N*01301 binding interactions. Figure shows the
binding interactions of the peptide Tp1214–224 with the cattle
MHC class I molecule N*01301. The classical binding pockets A–
F are labeled.
Found at: doi:10.1371/journal.ppat.1001149.s004 (5.44 MB TIF)
Figure S5 Different aspect views of the N*0301 binding groove in
complexwithTp1214–224. (A)Cartoon representation of the N*01301
presentation platform in white with the docked Tp1214–224 in stick
representation colored gold. The view looks down on the
presentation platform in the direction that incoming TCRs would
attempt docking. Residues of the six pockets have been colored as:
pocket A in red, pocket B in green, pocket C in blue, pocket D in
magenta, pocket E in brown and pocket F in cyan. (B) and (C)
molecular surface representation of the N*01301 allele with the
Tp1214–224 peptide in stick or surface representations respectively.
Different aspect views of the N*01301- Tp1214–224 complex in
cartoon and space-filling representations. Views (D) looking across
the interface from a1( a1 foreground, a2 background), (E) looking
down the binding groove with the N-terminus of the peptide in the
foreground, (F) looking across from a2( a2 foreground, a1
background) and (G) looking down the binding groove with the C-
terminus of the peptide in the foreground.
Found at: doi:10.1371/journal.ppat.1001149.s005 (4.50 MB
TIF)
Figure S6 CD8 recognition of Ala-substituted peptides. CD8
+ T
cell recognition of Tp1214–224 peptides containing Ala substitutions
in predicted anchor sites 2, 5, 11. Data are presented for clone
641.18 tested in a 4-hour
111Indium release cytotoxicity assay,
using target cells pulsed with the native peptide (solid diamonds)
and peptides containing Ala substitutions P11 (solid squares), P5
and P11 (open triangles) and P2, 5 and 11 (open circles).
Found at: doi:10.1371/journal.ppat.1001149.s006 (0.03 MB
DOC)
Table S1 Data collection, phasing, refinement statistics and
model quality.
Found at: doi:10.1371/journal.ppat.1001149.s007 (0.55 MB TIF)
Table S2 Analysis of solvent accessible surface buried in the
interface between MHC class I and the peptide presented.
Found at: doi:10.1371/journal.ppat.1001149.s008 (0.05 MB
DOC)
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